These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12918182)

  • 21. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.
    Zarama M; Raij L
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):100-7. PubMed ID: 8494007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Have rational therapeutic principles emerged in treating hypertension in chronic renal failure?
    de Zeeuw D; Gansevoort RT; de Jong PE
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):108-12. PubMed ID: 8494008
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal dysfunction complicating the treatment of hypertension.
    Palmer BF
    N Engl J Med; 2002 Oct; 347(16):1256-61. PubMed ID: 12393824
    [No Abstract]   [Full Text] [Related]  

  • 26. Regression of LVH or improved prognosis (or both): what is the question?
    Lip GY; Lydakis C; Zarifis J; Messerli FH
    J Hum Hypertens; 1998 Jul; 12(7):423-5. PubMed ID: 9702926
    [No Abstract]   [Full Text] [Related]  

  • 27. Home BP for assessing haemodialysis hypertension.
    Agarwal R
    Nephrol Dial Transplant; 2007 Oct; 22(10):3089-90; author reply 3090. PubMed ID: 17636055
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular findings in IgA nephropathy with renal failure and hypertension.
    Taban M; Chand D; Sears JE
    J Pediatr Ophthalmol Strabismus; 2006; 43(6):378-80. PubMed ID: 17162979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prehypertension is real and can be associated with target organ damage.
    Materson BJ; Garcia-Estrada M; Degraff SB; Preston RA
    J Am Soc Hypertens; 2017 Nov; 11(11):704-708. PubMed ID: 28965768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and kidney disease: a deadly connection.
    Barri YM
    Curr Hypertens Rep; 2008 Feb; 10(1):39-45. PubMed ID: 18367025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
    Georgianos PI; Agarwal R
    Am J Kidney Dis; 2015 Aug; 66(2):305-12. PubMed ID: 25818679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of preclinical target organ damage in hypertension: left ventricular hypertrophy.
    Rosei EA
    J Hypertens; 2001 Dec; 19(12):2288-90. PubMed ID: 11725178
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy.
    Bella JN
    Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.
    Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A
    Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical methods for the detection and management of left ventricular hypertrophy.
    Swamy RS; Lang RM
    Indian Heart J; 2010; 62(5):384-7. PubMed ID: 23189877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophy.
    Rosei EA
    Blood Press; 2003; 12(3):183-4. PubMed ID: 12875482
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes of cardiovascular system in patients with chronic renal failure].
    Shugushev KhKh; Khamizova MM; Vasilenko VM; Shugushev ZKh
    Kardiologiia; 2003; 43(3):75-9. PubMed ID: 12913985
    [No Abstract]   [Full Text] [Related]  

  • 40. Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure.
    Seeman T; Hradský O; Gilík J
    Eur J Pediatr; 2016 Aug; 175(8):1091-7. PubMed ID: 27344339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.